# Post Market Clinical Study - Evolution® Esophageal Stent Systems, Europe: Fully and Partially Covered

> **NCT05182255** · — · COMPLETED · sponsor: **Cook Research Incorporated** · enrollment: 127 (actual)

## Conditions studied

- Esophageal Diseases

## Interventions

- **DEVICE:** Evolution® Esophageal Stent Systems, Europe: Fully and Partially Covered

## Key facts

- **NCT ID:** NCT05182255
- **Lead sponsor:** Cook Research Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-28
- **Primary completion:** 2023-12-08
- **Final completion:** 2023-12-08
- **Target enrollment:** 127 (ACTUAL)
- **Last updated:** 2025-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05182255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05182255, "Post Market Clinical Study - Evolution® Esophageal Stent Systems, Europe: Fully and Partially Covered". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05182255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*